Potential of polylactic-co-glycolic acid (PLGA) for delivery Jembrana disease DNA vaccine Model (pEGFP-C1-tat)

BACKGROUND: The development of a vaccine for Jembrana disease is needed to prevent losses in Indonesia's Bali cattle industry. A DNA vaccine model (pEGFP-C1-tat) that requires a functional delivery system will be developed. Polylactic-co-glycolic acid (PLGA) may have potential as a delivery sys...

Descripción completa

Detalles Bibliográficos
Autores principales: Unsunnidhal, Lalu, Wasito, Raden, Nugraha Setyawan, Erif Maha, Warsani, Ziana, Kusumawati, Asmarani
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Veterinary Science 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8636661/
https://www.ncbi.nlm.nih.gov/pubmed/34697922
http://dx.doi.org/10.4142/jvs.2021.22.e76

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8636661/
https://www.ncbi.nlm.nih.gov/pubmed/34697922
http://dx.doi.org/10.4142/jvs.2021.22.e76

Ejemplares similares